Cargando…
p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer
FGFR signalling is one of the most prominent pathways involved in cell growth and development as well as cancer progression. FGFR1 amplification occurs in approximately 20% of all squamous cell lung carcinomas (SCC), a predominant subtype of non-small cell lung carcinoma (NSCLC), indicating FGFR as...
Autores principales: | Zarczynska, Izabela, Gorska-Arcisz, Monika, Cortez, Alexander Jorge, Kujawa, Katarzyna Aleksandra, Wilk, Agata Małgorzata, Skladanowski, Andrzej Cezary, Stanczak, Aleksandra, Skupinska, Monika, Wieczorek, Maciej, Lisowska, Katarzyna Marta, Sadej, Rafal, Kitowska, Kamila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699485/ https://www.ncbi.nlm.nih.gov/pubmed/34943871 http://dx.doi.org/10.3390/cells10123363 |
Ejemplares similares
-
MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells
por: Kitowska, Kamila, et al.
Publicado: (2021) -
FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
por: Mieczkowski, Kamil, et al.
Publicado: (2022) -
FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
por: Turczyk, Lukasz, et al.
Publicado: (2017) -
FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation
por: Mieczkowski, Kamil, et al.
Publicado: (2023) -
FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2022)